WallStSmart

American Healthcare REIT, Inc. (AHR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

American Healthcare REIT, Inc. stock (AHR) is currently trading at $47.94. American Healthcare REIT, Inc. PE ratio is 114.88. American Healthcare REIT, Inc. PS ratio (Price-to-Sales) is 4.02. Analyst consensus price target for AHR is $58.08. WallStSmart rates AHR as Underperform.

  • AHR PE ratio analysis and historical PE chart
  • AHR PS ratio (Price-to-Sales) history and trend
  • AHR intrinsic value — DCF, Graham Number, EPV models
  • AHR stock price prediction 2025 2026 2027 2028 2029 2030
  • AHR fair value vs current price
  • AHR insider transactions and insider buying
  • Is AHR undervalued or overvalued?
  • American Healthcare REIT, Inc. financial analysis — revenue, earnings, cash flow
  • AHR Piotroski F-Score and Altman Z-Score
  • AHR analyst price target and Smart Rating
AHR

American Healthcare REIT, Inc.

NYSEREAL ESTATE
$47.94
$0.31 (-0.64%)
52W$26.00
$54.67
Target$58.08+21.2%

📊 No data available

Try selecting a different time range

IV

AHR Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · American Healthcare REIT, Inc. (AHR)

Margin of Safety
-162.1%
Significantly Overvalued
AHR Fair Value
$19.66
Graham Formula
Current Price
$47.94
$28.28 above fair value
Undervalued
Fair: $19.66
Overvalued
Price $47.94
Graham IV $19.66
Analyst $58.08

AHR trades 162% above its Graham fair value of $19.66, indicating the stock may be overvalued at current levels.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

American Healthcare REIT, Inc. (AHR) · 9 metrics scored

Smart Score

46
out of 100
Grade: D+
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in eps growth, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.

American Healthcare REIT, Inc. (AHR) Key Strengths (3)

Avg Score: 9.0/10
EPS GrowthGrowth
306.20%10/10

Earnings per share surging 306.20% year-over-year

Institutional Own.Quality
97.70%10/10

97.70% of shares held by major funds and institutions

Market CapQuality
$9.07B7/10

Mid-cap company balancing growth potential with stability

Supporting Valuation Data

AHR Target Price
$58.08
16% Upside

American Healthcare REIT, Inc. (AHR) Areas to Watch (6)

Avg Score: 3.5/10
Return on EquityProfitability
2.50%1/10

Very low returns on shareholder equity

Operating MarginProfitability
6.68%2/10

Very thin margins with limited operational efficiency

Profit MarginProfitability
3.09%2/10

Very thin margins, barely profitable

Price/SalesValuation
4.024/10

Premium valuation at 4.0x annual revenue

Price/BookValuation
2.726/10

Fairly priced relative to book value

Revenue GrowthGrowth
11.90%6/10

Solid revenue growth at 11.90% per year

Supporting Valuation Data

P/E Ratio
114.88
Overvalued
Forward P/E
61.73
Expensive
Trailing P/E
114.88
Overvalued

American Healthcare REIT, Inc. (AHR) Detailed Analysis Report

Overall Assessment

This company scores 46/100 in our Smart Analysis, earning a D+ grade. Out of 9 metrics analyzed, 3 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 3.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on EPS Growth, Institutional Own., Market Cap. Growth metrics are encouraging with EPS Growth at 306.20%.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Sales (4.02), Price/Book (2.72) suggest expensive pricing. Growth concerns include Revenue Growth at 11.90%, which may limit upside. Profitability pressure is visible in Return on Equity at 2.50%, Operating Margin at 6.68%, Profit Margin at 3.09%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 2.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 11.90% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

AHR Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

AHR's Price-to-Sales ratio of 4.02x trades at a 26% premium to its historical average of 3.18x (66th percentile). The current valuation is 15% below its historical high of 4.7x set in Feb 2026, and 195% above its historical low of 1.36x in Feb 2024. Over the past 12 months, the PS ratio has expanded from ~2.7x, reflecting growing market expectations outpacing revenue growth.

Compare AHR with Competitors

Top REIT - HEALTHCARE FACILITIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for American Healthcare REIT, Inc. (AHR) · REAL ESTATEREIT - HEALTHCARE FACILITIES

The Big Picture

American Healthcare REIT, Inc. is a mature, profitable business with steady cash generation. Revenue reached 2.3B with 12% growth year-over-year. Profit margins are strong at 309.0%, reflecting pricing power and operational efficiency.

Key Findings

Excellent Capital Efficiency

ROE of 250.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.

Negative Free Cash Flow

Free cash flow is -14M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.

What to Watch Next

Valuation compression risk at a P/E of 114.9x. Any growth miss could trigger a sharp correction.

Debt management: total debt of 1.7B is significantly higher than cash (147M). Monitor refinancing risk.

Sector dynamics: monitor REIT - HEALTHCARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact American Healthcare REIT, Inc..

Bottom Line

American Healthcare REIT, Inc. is a well-established business delivering consistent profitability with 309.0% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About American Healthcare REIT, Inc.(AHR)

Exchange

NYSE

Sector

REAL ESTATE

Industry

REIT - HEALTHCARE FACILITIES

Country

USA

American Healthcare REIT, Inc. is a prominent real estate investment trust focused on the acquisition and management of a diversified portfolio of high-quality healthcare facilities across the United States. Specializing in senior housing, skilled nursing, and medical office properties, the company collaborates with leading operators to guarantee stable cash flows and sustainable growth. By prioritizing the enhancement of resident and patient quality of life, American Healthcare REIT is strategically positioned to benefit from the expanding healthcare real estate sector, presenting a compelling investment opportunity for institutional investors in an essential services market.

Visit American Healthcare REIT, Inc. (AHR) Website
18191 VON KARMAN AVENUE, IRVINE, CA, UNITED STATES, 92612-7106